Barely Significant
← all excerpts

Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy.

Virol J · 2024 · PMC10993446 · PMID 38570803

Europe PMCDOI
1
hedged sentence
0.0530
closest p · 1.1× alpha
0.0530
boldest claim

The sentences

borderline significantP = 0.053so close (0.05 < p ≤ 0.1)
There was borderline significant difference in virological relapse rate was detected between the entecavir and TAF groups ( P = 0.053, Fig. 1 A).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.